The FDA has recently required drug companies to provide warnings on the labels of all antidepressants because of evidence that these drugs may induce
a. suicidal ideation or behaviors in a small proportion of depressed patients at the beginning of their treatment
b. parkinsonian-like symptoms in elderly patients
c. hypertensive crises when combined with certain foods or other drugs
d. convulsions in certain patients
Question 2
Recent evidence suggests that monoamine oxidase inhibitors have the greatest efficacy in the treatment of
a. atypical depressions
b. schizophrenics
c. manic patients
d. bipolar depressives
Pharmacogenomics, Genetic makeup, Drug development, Individual response to drugs, Prescriptions
The declining age of menarche over the past 150 years has been measured in many European countries,
Competitive drug enzyme immunoassay.
Graph showing oral administration of a single-dose drug. The time of onset is 2 hours and the end of ...
Growing plants in a container garden can provide healthy, nutritious vegetables for your dinner
Drug-drug interactions